Assignee
ASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD
CN·9 granted patents·4 pending applications·9 citations·filing 2016–2023
Top patents by PatentIndex Score
13 records- 0186US11738051B2Nucleotide sequences for encoding CAR, ROBO1 CAR-NK cells of expressing the CAR, and preparation and application thereofASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2020·Granted Aug 29, 2023·2 cites·11 claims
- 0284US11697685B2Chimeric antigen receptor cells targeting ROBO1, preparation method and use thereofASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2019·Granted Jul 11, 2023·3 cites·8 claims
- 0383US11345893B2Anti-ROBO1 CAR-T cell, and preparation and application thereofASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2016·Granted May 31, 2022·2 cites·4 claims
- 0481US11339225B2Bispecific antigen-binding construct and preparation method and use thereofASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2017·Granted May 24, 2022·2 cites·3 claims
- 0570US12486324B2Chimeric antigen receptor cells targeting ROBO1, preparation method and use thereofASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2023·Granted Dec 2, 2025·0 cites·13 claims
- 0666US2022267731A1Anti-robo1 car-t cell, and preparation and application thereofASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2022·Application pending·0 cites
- 0760US11331345B2PD-1 CAR NK-92 cell and preparation method and use thereofASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2019·Granted May 17, 2022·0 cites·19 claims
- 0858US11680106B2Bispecific antigen-binding construct and preparation method and use thereofASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2022·Granted Jun 20, 2023·0 cites·5 claims
- 0956US2021401957A1Robo1 car-nk cell carrying suicide gene, preparation method and application thereofASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2021·Application pending·0 cites
- 1054US11246888B2Slit2D2-chimeric antigen receptor and application thereofASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2018·Granted Feb 15, 2022·0 cites·8 claims
- 1149US2020360437A1Chimeric antigen receptor, nkg2d car-nk cells expressing the chimeric antigen receptor, and preparation and application thereofASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2020·Application pending·0 cites
- 1248US11149071B2Fusion protein Slit2D2(C386S)-HSA and use thereof in prevention and/or treatment of lung inflammationASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2019·Granted Oct 19, 2021·0 cites·3 claims
- 1339US2019117691A1Pd-1 car-t cell, preparation method therefor, and application thereofASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ASCLEPIUS SUZHOU TECH COMPANY GROUP CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →